Exelixis, Inc. (EXEL) fundamentals chart
EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/305% above fair value
$68.29−0.21 (-0.31%)
Close on Nov 18, 2026Market cap $16.66BP/E 20.4Yield –
Fundamental chart
Pick a measure to chart its full history
$2.32BFY2025, +16.0% a year since FY2011
See a number that looks wrong?